Ownership

John M. Leonard - President and CEO, Director at Intellia Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: President and CEO, Director
Stock Symbol: NTLA on Nasdaq
Industry: In Vitro & In Vivo Diagnostic Substances
All Insider Reports: All Insider Reports

John M. Leonard - trading volume in the past year for Intellia Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-26.8K	100%	$12.18	-$327K
Net	-26.8K	-100%		-$327K

Holdings reported by John M. Leonard for Intellia Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	941K	$11.5M	$12.18	Jan 3, 2025	Direct
Common Stock	58.4K	$711K	$12.18	Jan 3, 2025	By Trust
Restricted Stock Unit	0	$0	$19.01	Jan 1, 2025	Direct	Common Stock
Stock Option (right to buy)	164K			Mar 1, 2024	Direct	Common Stock

Transactions reported by John M. Leonard for Intellia Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.